- Open Access
The concentration of oxygen, lactate and glucose in the central veins, right heart, and pulmonary artery: a study in patients with pulmonary hypertension
Critical Care volume 11, Article number: R44 (2007)
Decreases in oxygen saturation (SO2) and lactate concentration [Lac] from superior vena cava (SVC) to pulmonary artery have been reported. These gradients (ΔSO2 and Δ[Lac]) are probably created by diluting SVC blood with blood of lower SO2 and [Lac]. We tested the hypothesis that ΔSO2 and Δ[Lac] result from mixing SVC and inferior vena cava (IVC) blood streams.
This was a prospective, sequential, observational study of hemodynamically stable individuals with pulmonary artery hypertension (n = 9) who were about to undergo right heart catheterization. Catheters were advanced under fluoroscopic guidance into the IVC, SVC, right atrium, right ventricle, and pulmonary artery. Samples were obtained at each site and analyzed for SO2, [Lac], and glucose concentration ([Glu]). Analysis of variance with Tukey HSD test was used to compare metabolite concentrations at each site.
There were no differences in SO2 or [Lac] between IVC and SVC, both being greater than their respective pulmonary artery measurements (P < 0.01 for SO2 and P < 0.05 for [Lac]). SO2 and [Lac] in right atrium, right ventricle, and pulmonary artery were similar. ΔSO2 was 4.4 ± 1.4% (mean ± standard deviation) and Δ[Lac] was 0.16 ± 0.11 mmol/l (both > 0; P < 0.001). Δ[Glu] was -0.19 ± 0.31 mmol/l, which was not significantly different from zero, with SVC [Glu] being less than IVC [Glu].
Mixing of SVC with IVC blood does not account for the development of ΔSO2 and Δ[Lac] in hemodynamically stable individuals with pulmonary artery hypertension. An alternate mechanism is mixing with coronary sinus blood, implying that ΔSO2 and Δ[Lac] may reflect changes in coronary sinus SO2 and [Lac] in this patient population.
Blood oxygen saturation (SO2) in the superior vena cava (SVC) is approximately 2% to 5% higher than that in the pulmonary artery [1, 2]. This SVC-pulmonary artery gradient in SO2 varies considerably among individuals, or even within the same person when it is measured at different times . Declines in blood lactate concentration ([Lac]) from right atrium to pulmonary artery (Δ[Lac]) have also been reported . The SO2 and [Lac] gradients (ΔSO2 and Δ[Lac]) probably develop as SVC blood mixes with blood from the inferior vena cava (IVC) or from the heart's venous drainage, comprised of blood emanating from the coronary sinus and Thebesian veins; alternatively (and more likely), blood from both sources mixes at varying proportions .
Monitoring ΔSO2 and Δ[Lac] may be of little clinical interest if these gradients are produced exclusively by mixing of SVC and IVC blood streams. On the other hand, if ΔSO2 and Δ[Lac] result from mixing of SVC with coronary venous blood, either in part or in whole, then it is possible for these gradients to reflect alterations in myocardial oxidative metabolism [4, 6]. The heart is the most aerobic of organs, normally deriving its energy from the oxidation of free fatty acids and lactate, and coronary venous blood normally has the lowest SO2 of any venous blood . Moreover, myocardial lactate oxidation accounts for 10% to 20% of total myocardial aerobic energy production, and coronary venous [Lac] is substantially lower than that of other venous effluents .
To test the hypothesis that ΔSO2 and Δ[Lac] result exclusively from mixing of SVC and IVC blood streams, we measured concentrations of oxygen and [Lac] in the central veins, the right heart chambers, and the pulmonary artery of hemodynamically stable individuals who were about to undergo right heart catheterization. Additionally, we measured the glucose concentration ([Glu]) in the aforementioned sites, because this substrate is also known to play an important role in myocardial energy metabolism.
Materials and methods
This was a prospective, sequential observational study conducted in persons of either sex admitted to The George Washington University Hospital with a diagnosis of pulmonary artery hypertension who were scheduled to undergo right heart catheterization. The institutional review board approved the study with the exclusion of drawing arterial blood samples. All patients underwent cardiac catheterization in order to evaluate cardiac function and pulmonary artery pressures, and were not healthy volunteers. Written informed consent was obtained from each patient.
Nine individuals who were older than 18 years, of either sex, were enrolled sequentially in the study. All patients were ambulatory. Patients were sedated before the procedure with 4 to 8 mg midazolam intravenously. Electrocardiograph leads were monitored continuously and arterial blood pressure was measured in the right arm at 1 min intervals using an automated inflatable blood pressure measuring device. Supplemental oxygen by mask was given to maintain arterial SO2, measured by pulse oximetry, above 98% at all times during the procedure. An 8 Fr venous sheath was placed in the right femoral vein and a 7 Fr Van Aman pigtail catheter (Cook, Bloomington, IN, USA) was inserted under sterile technique and guided under fluoroscopy into the IVC just above the diaphragm (IVC site). It was then advanced successively into the SVC, approximately 5 cm above the right atrium (SVC site), the right atrium (right atrium site), the right ventricle (right ventricle site), and pulmonary artery (pulmonary artery site). A small amount of non-ionic contrast media was injected with the catheter in the right atrium to rule out the presence of a patent foramen ovale or septal defects. In one individual the catheter was inserted through the right jugular vein and proper positioning at sampling each site was also confirmed fluoroscopically. Measurement of hydrostatic blood pressure at each site was followed by the drawing of 1.5 ml blood aliquots, with the first 2 ml of blood drawn from the catheter discarded to prevent contamination with flushing fluid. The Van Aman catheter was removed and exchanged for a 7.5 Fr pulmonary artery catheter (Swan-Ganz standard thermodilution pulmonary artery catheter; Edwards Life Sciences, Irvine, CA, USA) and measurements were taken of cardiac output in triplicate using the thermodilution method and pulmonary artery occlusion pressure. Cardiac index was computed by dividing cardiac output by the patient's body surface area.
Blood samples were immediately placed in ice and promptly analyzed in triplicate  for SO2 saturation (IL682 CO-Oximeter; Instrumentation Laboratories, Lexington, MA, USA), and [Lac] and [Glu] (YSI 2300 STAT Plus Lactate/Glucose Instrument; YSI Company, Yellow Springs, OH, USA). The YSI 2300 STAT Plus measures [Lac] and [Glu] in whole blood and has been used in studies of blood [Lac] in critically ill individuals [10.11]. The accuracy of whole blood lactate measurements, as compared with those in plasma, was previously established . The reported precision of blood lactate measurements  with the YSI 2300 STAT Plus is 0.06 mmol/l for lactate values below 2.5 mmol/l. In the present study, we found the precision of the three repeated measurements to be 0.86% for SO2, 0.09 mmol/l for [Lac], and 0.21 mmol/L for [Glu].
Analysis of variance for repeated measures was used to compare mean SO2, [Lac], and [Glu] at each sampling site. The Tukey HSD test  was performed for multiple comparisons among sampling sites whenever the F ratio was significant. The gradient Δ in the various parameters is defined as the difference between SVC and pulmonary artery. Unless stated otherwise, data are expressed as mean ± standard deviation, with P < 0.05 denoting a statistically significant difference.
Table 1 shows mean hydrostatic blood pressures measured at each sampling site as well as pulmonary artery occlusion pressure, mean arterial pressure, and cardiac index. Table 2 shows individual SO2 and [Lac] measured at each sampling site, and Figure 1 shows graphs of mean ± standard error values for SO2 and [Lac]. There were no differences in SO2 between IVC and SVC. SO2 levels at the IVC and SVC were greater than that at the pulmonary artery (P < 0.01) and were greater than SO2 at the right atrium and right ventricle sites (P < 0.01 for IVC and P < 0.05 for SVC). There were no differences in SO2 among right atrium, right ventricle, and pulmonary artery sites. ΔSO2 was 4.4 ± 1.4%, which was significantly different from zero (P < 0.001).
There were no differences in [Lac] between the IVC and SVC sites. IVC [Lac] and SVC [Lac] were greater than pulmonary arterial [Lac] (P < 0.01 for IVC and P < 0.05 for SVC). IVC [Lac] was also greater than right atrial and right ventricular [Lac]. There were no differences in [Lac] among right atrium, right ventricle and pulmonary artery sites. Δ[Lac] was 0.16 ± 0.11 mmol/l, which was significantly different from zero (P < 0.001).
Figure 2 shows the [Glu] values for each sampling site. [Glu] at the SVC was significantly lower than that at the IVC, right atrium, and right ventricle sites (P < 0.01, P < 0.05, and P < 0.05, respectively). There were no differences in [Glu] among the IVC, right atrium, right ventricle, and pulmonary artery sites. Δ[Glu] was -0.19 ± 0.31 mmol/l, which was not significantly different from zero.
The aim of the present study was to test the hypothesis that the mechanism responsible for the development of SO2 and [Lac] gradients from SVC to pulmonary artery is mixing of SVC with IVC blood. To that end, we measured the steady state concentration of oxygen and [Lac] in the central veins, the right heart chambers, and the pulmonary artery in hemodynamically stable individuals who were suspected of having elevated pulmonary artery pressures.
Several studies [1–3, 15–26] have compared SO2 in SVC with that in the pulmonary artery. The majority of these studies found decreases in SO2 as blood travels from SVC to pulmonary artery. The average ΔSO2 of 4.4% found in the present study agrees with mean values of 3% to 5% reported by others. According to our results, however, mixing of SVC with IVC blood cannot account for the development of ΔSO2 and Δ[Lac], as noted in this patient population. The average concentrations of oxygen and lactate in SVC and IVC blood were indistinguishable from each other. Moreover, SO2 and [Lac] in the SVC and IVC were both greater than the respective pulmonary artery values. Therefore, it would be physically impossible for the mixing of SVC and IVC blood streams to produce pulmonary artery blood of lesser SO2 and [Lac].
The numerical average of IVC and SVC SO2 (mean SO2 = [IVC SO2 + SVC SO2]/2) provides a first order estimate of right atrial SO2. Assuming no input whatever from other venous sources, such as coronary sinus, the estimate for right atrial SO2 computed in this manner should equal pulmonary arterial SO2. Table 3 shows differences between computed mean SO2 and pulmonary arterial SO2 reported in published studies measuring SO2 in the central veins, the right heart, and pulmonary artery in humans [27–31]. With the exception of a subset of eight patients who were 'not in shock', reported by Lee and coworkers , all studies find that mean SO2 was greater than pulmonary arterial SO2. The combined average difference for the group is 1.82 ± 0.78%, a value significantly different from zero (P < 0.05). These data also fail to support the hypothesis of mixing SVC with IVC blood as the sole mechanism for ΔSO2 in hemodynamically stable individuals. Given that two-thirds of the systemic venous return in adults is via the IVC , the magnitude of the difference between mean SO2 and pulmonary arterial SO2 would have been even greater if more weight had been placed on IVC SO2 in the computation of mean SO2.
Few studies have reported on the distribution of SO2 in the central veins and right heart in shock states. Lee and coworkers  noted that IVC SO2 and SVC SO2 were 49.1% and 65.8%, respectively, in five patients with cardiogenic shock (cardiac index 1.7 l/min per m2). Pulmonary arterial SO2 was nearly equal to the computed mean SO2, indicating a predominant role for IVC SO2 in the formation of ΔSO2. No comparable studies in septic shock have been reported. Dahn and coworkers  measured hepatic venous SO2 in 15 septic patients and found a normal pulmonary arterial SO2 of 70.5% at a time when hepatic venous SO2 was 55.6%. Similar findings were reported by De Backer and colleagues , who measured hepatic venous SO2 in 42 septic patients and noted pulmonary arterial SO2 and hepatic venous SO2 to be 67.3% and 50.3%, respectively. Little insight can be gained from these data into the genesis of ΔSO2 in septic shock, because neither IVC SO2 nor SVC SO2 were measured in these studies.
Ours is the only study to report the distribution of [Lac] in the central vasculature, and only two other studies have compared lactate concentrations in SVC and pulmonary artery. Weil and coworkers  found no differences between SVC [Lac] and pulmonary arterial [Lac] in 12 patients. Conversely, we measured a Δ[Lac] of 0.2 mmol/l in 45 critically ill individuals in which blood samples were obtained from the proximal and distal ports of pulmonary artery catheters . The present study corroborates our previous finding that a measurable [Lac] gradient exists between SVC and pulmonary artery. We also noted that pulmonary arterial [Lac] was lower than either SVC [Lac] or IVC [Lac], a finding that also refutes the idea of mixing SVC and IVC blood as the mechanism for development of Δ[Lac].
The finding of greater SO2 and [Lac] in IVC and SVC than in pulmonary artery indicates that further dilution of oxygen and [Lac] takes place as blood flows through the right heart chambers. Given the vigorous myocardial extraction of oxygen and lactate, venous concentrations of those chemical species are lowest in coronary venous blood, which includes blood emanating from coronary sinus and the Thebesian system. Therefore, it is possible that blood flowing from the coronary sinus and Thebesian veins exerted a small but measurable diluting effect on right atrial SO2 and right atrial [Lac]. We lacked direct samples of coronary venous blood and cannot prove this hypothesis conclusively from the data presented. Lending support this notion, however, are the observations that significant decreases in SO2 and [Lac] occurred mainly in the right atrium, which is the anatomical location of the coronary sinus (Figure 1).
We found that the distribution pattern for [Glu] differed from those of SO2 and [Lac]. SVC [Glu] was lower than IVC [Glu], reflecting the high rate of cerebral glucose uptake. In adult humans glucose represents the main, if not the sole, substrate of brain energy metabolism, with the brain utilizing approximately 25% of circulating blood glucose [36, 37]. In contrast to the distributions noted for SO2 and [Lac], right atrial [Glu] was greater than SVC [Glu] but nearly equal to IVC [Glu]. This concentration distribution is that expected for a metabolite whose coronary sinus concentration approximates that of SVC blood, such as may be the case for glucose in fully aerobic conditions . It remains to be seen whether the [Glu] pattern changes with myocardial hypoxia, as glucose becomes the preferred metabolic substrate of the heart and coronary sinus [Glu] declines in relation to IVC [Glu] .
The individuals studied had elevated pulmonary arterial pressures, and patients with pulmonary arterial hypertension frequently have right-sided valvular regurgitation, right ventricular dilatation, and right-to-left shunts through a patent foramen ovale. Angiography did not reveal patent foramina or septal defects in any of the patients included in this study. Given their moderate severity of pulmonary arterial hypertension, right ventricular dilatation and pulmonary and tricuspid regurgitation in this particular group of patients were likely to have been modest. On the other hand, it is conceivable that retrograde transvalvular flow through the pulmonary valve could have affected right ventricular and pulmonary arterial values. Samples were obtained sequentially, not simultaneously, and the possibility exists that temporal changes in concentration occurred in the different sampling sites as the catheter was advanced into the pulmonary artery. To avoid this possibility, care was taken to verify with fluoroscopy the position of the catheter at each sampling site and the blood sampling procedure was performed within a span of 5 min, with no changes noted in heart rate or blood pressure in any of the patients. Finally, Δ[Lac] and Δ[Glu] were small when compared with the precision of the measuring instrument. This raises an important question regarding the utility of single measurements of Δ[Lac] and Δ[Glu], a question that only can be answered by further clinical studies.
The development of ΔSO2 and Δ[Lac] in the patient population studied cannot be explained by the mixing of SVC and IVC blood. The development of these gradients appears to require mixing with blood of lower SO2 and [Lac], most likely blood emanating from the coronary sinus and Thebesian veins. Because coronary venous blood SO2 and [Lac] vary according to the rates of oxygen and lactate utilization by the heart, this mechanism suggests a possible role for ΔSO2 and Δ[Lac] as markers of myocardial energy metabolism in hemodynamically stable individuals . Further work remains to be done to establish the provenance of these gradients in other clinical conditions, including shock states .
Blood SO2 and [Lac] gradients exist from SVC to pulmonary artery.
These gradients were not produced by mixing of SVC blood with IVC blood in a population of patients with mild-to-moderate pulmonary hypertension.
Decreases in SO2 and [Lac] were noted to be greatest in the right atrium, suggesting that mixing of SVC with coronary venous blood is the primary mechanism resulting in ΔSO2 and Δ[Lac].
Coronary venous blood SO2 and [Lac] vary according to their rates of utilization by the heart, and so it may be possible for ΔSO2 and Δ[Lac] to serve as markers of myocardial energy metabolism in the patient population studied.
inferior vena cava
superior vena cava.
Chawla LS, Zia H, Gutierrez G, Katz NM, Seneff MG, Shah M: Lack of equivalence between central and mixed venous oxygen saturation. Chest 2004, 126: 1891-1896. 10.1378/chest.126.6.1891
Edwards JD, Mayall RM: Importance of the sampling site for measurement of mixed venous oxygen saturation in shock. Crit Care Med 1998, 26: 1356-1360. 10.1097/00003246-199808000-00020
Reinhart K, Kuhn HJ, Hartog C, Bredle DL: Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med 2004, 30: 1572-1578. 10.1007/s00134-004-2337-y
Gutierrez G, Chawla LS, Seneff MG, Katz NM, Zia H: Lactate concentration gradient from right atrium to pulmonary artery. Crit Care 2005, 9: R425-R429. 10.1186/cc3489
Rivers E: Mixed vs. central venous oxygen saturation may not be numerically equal, but both are still clinically useful. Chest 2006, 129: 507-508. 10.1378/chest.129.3.507
Creteur J: Lactate concentration gradient from right atrium to pulmonary artery: a commentary. Crit Care 2005, 9: 337-338. 10.1186/cc3769
Abel ED: Glucose transport in the heart. Front Biosci 2004, 9: 201-215. 10.2741/1216
Stanley WC, Chandler MP: Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Fail Rev 2002, 7: 115-130. 10.1023/A:1015320423577
De Backer D, Creteur J, Zhang H, Norrenberg M, Vincent JL: Lactate production by the lungs in acute lung injury. Am J Respir Crit Care Med 1997, 156: 1099-1104.
Brown SD, Clark C, Gutierrez G: Pulmonary lactate release in patients with sepsis and the adult respiratory distress syndrome. J Crit Care 1996, 11: 2-8. 10.1016/S0883-9441(96)90014-3
Kellum JA, Kramer DJ, Lee K, Mankad S, Bellomo R, Pinsky MR: Release of lactate by the lung in acute lung injury. Chest 1997, 111: 1301-1305.
Clark LC Jr, Noyes LK, Grooms TA, Moore MS: Rapid micromeasurement of lactate in whole blood. Crit Care Med 1984, 12: 461-464. 10.1097/00003246-198405000-00011
Walsh TS, McLellan S, Mackenzie SJ, Lee A: Hyperlactatemia and pulmonary lactate production in patients with fulminant hepatic failure. Chest 1999, 116: 471-476. 10.1378/chest.116.2.471
Zar JH: Simple linear correlation. In Biostatistical Analysis. 4th edition. Upper Saddle River, NJ: Prentice-Hall, Inc; 1999:377-383.
Berridge JC: Influence of cardiac output on the correlation between mixed venous and central venous oxygen saturation. Br J Anaesth 1992, 69: 409-410. 10.1093/bja/69.4.409
Dueck MH, Klimek M, Appenrodt S, Weigand C, Boerner U: Trends but not individual values of central venous oxygen saturation agree with mixed venous oxygen saturation during varying hemodynamic conditions. Anesthesiology 2005, 103: 249-257. 10.1097/00000542-200508000-00007
Faber T: Central venous versus mixed venous oxygen content. Acta Anaesthesiol Scand Suppl 1995, 107: 33-36.
Herrera A, Pajuelo A, Morano MJ, Ureta MP, Gutierrez-Garcia J, de las Mulas M: Comparison of oxygen saturations in mixed venous and central blood during thoracic anesthesia with selective single-lung ventilation [in Spanish]. Rev Esp Anestesiol Reanim 1993, 40: 349-353.
Ladakis C, Myrianthefs P, Karabinis A, Karatzas G, Dosios T, Fildissis G, Gogas J, Baltopoulos G: Central venous and mixed venous oxygen saturation in critically ill patients. Respiration 2001, 68: 279-285. 10.1159/000050511
Martin C, Auffray JP, Badetti C, Perrin G, Papazian L, Gouin F: Monitoring of central venous oxygen saturation versus mixed venous oxygen saturation in critically ill patients. Intensive Care Med 1992, 18: 101-104. 10.1007/BF01705041
Pieri M, Brandi LS, Bertolini R, Calafa M, Giunta F: Comparison of bench central and mixed pulmonary venous oxygen saturation in critically ill postsurgical patients [in Italian]. Minerva Anestesiol 1995, 61: 285-291.
Scheinman MM, Brown MA, Rapaport E: Critical assessment of use of central venous oxygen saturation as a mirror of mixed venous oxygen in severely ill cardiac patients. Circulation 1969, 40: 165-172.
Tahvanainen J, Meretoja O, Nikki P: Can central venous blood replace mixed venous blood samples? Crit Care Med 1982, 10: 758-761.
Turnaoglu S, Tugrul M, Camci E, Cakar N, Akinci O, Ergin P: Clinical applicability of the substitution of mixed venous oxygen saturation with central venous oxygen saturation. J Cardiothorac Vasc Anesth 2001, 15: 574-579. 10.1053/jcan.2001.26534
Wendt M, Hachenberg T, Albert A, Janzen R: Mixed venous versus central venous oxygen saturation in intensive medicine [in German]. Anasth Intensivther Notfallmed 1990, 25: 102-106.
Varpula M, Karlsson S, Ruokonen E, Pettila V: Mixed venous oxygen saturation cannot be estimated by central venous oxygen saturation in septic shock. Intensive Care Med 2006, 32: 1336-1343. 10.1007/s00134-006-0270-y
Barratt-Boyes BG, Wood EH: The oxygen saturation of blood in the vena cavae, right heart chambers and pulmonary vessels of healthy subjects. J Lab Clin Med 1957, 50: 93-106.
Gasul BM, Arcilla RA, Lev M: Heart Disease in Children: Diagnosis and Treatment. Philadelphia, PA: JB Lippincott Co; 1960:190.
Gutgesell HP, Williams RL: Caval samples as indicators of mixed venous oxygen saturation: Implications in atrial septal defect. Cardiovasc Dis 1974, 1: 160-164.
Kjellberg SR, Mannheimer E, Rudhe U, Jonsson B: Diagnosis of Congenital Heart Disease. Chicago, IL: The Yearbook Publishers, Inc; 1959:123-124.
Lee J, Wright F, Barber R, Stanley L: Central venous oxygen saturation in shock: a study in man. Anesthesiology 1972, 36: 472-478. 10.1097/00000542-197205000-00012
Salim MA, DiSessa TG, Arheart KL, Alpert BS: Contribution of superior vena caval flow to total cardiac output in children. A Doppler echocardiographic study. Circulation 1995, 92: 1860-1865.
Dahn MS, Lange MP, Jacobs LA: Central mixed and splanchnic venous oxygen saturation monitoring. Intensive Care Med 1988, 14: 373-378. 10.1007/BF00262891
De Backer D, Creteur J, Noordally O, Smail N, Gulbis B, Vincent JL: Does hepato-splanchnic VO 2 /DO 2 dependency exist in critically ill septic patients? Am J Respir Crit Care Med 1998, 157: 1219-1225.
Weil MH, Michaels S, Rackow EC: Comparison of blood lactate concentrations in central venous, pulmonary artery, and arterial blood. Crit Care Med 1987, 15: 489-490. 10.1097/00003246-198705000-00006
Robinson PJ, Rapoport SI: Glucose transport and metabolism in the brain. Am J Physiol 1986, 250: R127-R136.
Zauner A, Muizelaar JP: Brain metabolism and cerebral blood flow. In Head Injury. Edited by: Reilly P, Bullock R. London, UK: Chapman and Hall; 1997:89-99.
Dhainaut JF, Huyghebaert MF, Monsallier JF, Lefevre G, Dall'Ava-Santucci J, Brunet F, Villemant D, Carli A, Raichvarg D: Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 1987, 75: 533-541.
Funds to conduct this research were provided in part by a Research Grant from The Richard B. and Lynne V Cheney Cardiovascular Institute and by an internal research grant from The George Washington University Pulmonary and Critical Care Medicine Division.
GG has served in the past as consultant to Hospira, Inc., a manufacturer of pulmonary artery catheters. Hospira Inc. was not involved in any aspect of the study. GG holds a patent on a method related to the subject matter of the study. None of the other authors declare any competing interests.
GG conceived and designed the study, analyzed, interpreted the data and wrote and reviewed the manuscript. AV acquired data and reviewed the manuscript. EI designed the study, acquired data, and reviewed the manuscript. JR acquired data, and reviewed the manuscript. LC designed the study, and reviewed the manuscript. AD designed the study, acquired data, and wrote and reviewed the manuscript.
About this article
Cite this article
Gutierrez, G., Venbrux, A., Ignacio, E. et al. The concentration of oxygen, lactate and glucose in the central veins, right heart, and pulmonary artery: a study in patients with pulmonary hypertension. Crit Care 11, R44 (2007). https://doi.org/10.1186/cc5739
- Pulmonary Artery
- Inferior Vena Cava
- Pulmonary Arterial Hypertension
- Coronary Sinus
- Superior Vena Cava